Kidswell Bio Overview

  • Founded
  • 2001

Founded
  • Status
  • Public

  • Employees
  • 38

Employees
  • Stock Symbol
  • 4584

Stock Symbol
  • Investments
  • 4

  • Share Price
  • $1.64

  • (As of Friday Closing)

Kidswell Bio General Information

Description

Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.

Contact Information

Formerly Known As
Gene Techno Science Co., Ltd., Gene Techno, Gene Techno Science Co, Gene Techno Sciences, Gene Techno Science
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
TKS
Primary Office
  • 3rd Floor, Kanayama Building
  • 1-2-12, Shinkawa
  • Tokyo, Chuo-ku
  • Japan
+81 00-0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kidswell Bio Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.64 $1.62 $1.35 - $2.65 $52.1M 32.1M 117K -$0.16

Kidswell Bio Financials Summary

In Thousands,
USD
TTM 31-Dec-2022 FY 2022 31-Mar-2022 FY 2021 31-Mar-2021 FY 2020 31-Mar-2020
EV 65,267 113,670 126,657 122,502
Revenue 14,555 13,968 9,398 9,912
EBITDA (4,593) (9,271) (67,218)
Net Income (4,838) (4,764) (9,444) (67,288)
Total Assets 31,829 28,705 35,661 33,238
Total Debt 15,825 5,735 9,971 11,335
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kidswell Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Kidswell Bio‘s full profile, request access.

Request a free trial

Kidswell Bio Patents

Kidswell Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-WO2019216438-A1 Periodontal disease therapeutic agent containing culture supernatant of mesenchymal cells Pending 11-May-2018
CA-3075867-A1 Anti-ramp2 antibody Inactive 13-Sep-2017
JP-WO2019054460-A1 Anti-ramp2 antibody Active 13-Sep-2017 0
JP-2022169737-A Anti-ramp2 antibody Pending 13-Sep-2017
US-20200270579-A1 Method for preparing dental pulp stem cells from cells derived from dental pulp tissue Inactive 03-Feb-2017 C12N5/0664
To view Kidswell Bio’s complete patent history, request access »

Kidswell Bio Executive Team (5)

Name Title Board Seat Contact Info
Masaharu Tani President & Chief Executive Officer
Masanari Kawaminami President & Board Member
Yasuo Sakae Chief Financial Officer
Masayuki Kawakami Chief Operating Officer, Corporate Officer & Chief Technology Officer
Yoshikazu Amano Fellow , Research & Development and Business Development
To view Kidswell Bio’s complete executive team members history, request access »

Kidswell Bio Board Members (1)

Name Representing Role Since
Masanari Kawaminami Kidswell Bio President & Board Member 000 0000
To view Kidswell Bio’s complete board members history, request access »

Kidswell Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kidswell Bio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Kidswell Bio‘s full profile, request access.

Request a free trial

Kidswell Bio Investments & Acquisitions (4)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 11-Mar-2020 00000 0000 000.00 Drug Discovery
00000000 0000 17-Jan-2019 0000000000 Other Healthcare Services
00000000 0000 30-Mar-2018 00000 0000 Other Healthcare Services
OrthoReBirth 27-Nov-2014 Seed Round 00.00 Other Devices and Supplies 00000000
To view Kidswell Bio’s complete investments and acquisitions history, request access »

Kidswell Bio ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Kidswell Bio’s complete esg history, request access »

Kidswell Bio Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 0000 0000 17-Jan-2019 000000000000000000 Completed
  • 00000000 000
Advanced Cell Technology and Engineering 30-Mar-2018 Later Stage VC Completed
  • 2 buyers
To view Kidswell Bio’s complete exits history, request access »